Management of the patient with coagulation disorders
Authors:
- Jim ChandlerJCJim Chandler
- Ray LatimerRLRay Latimer
- Alain VuylstekeAVAlain Vuylsteke
- 1 February 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 15 (1) , 19-25
Abstract
Understanding normal haemostasis and the pathophysiology of its disorders is essential for providing optimal care and ensuring judicious usage of blood products, as is keeping abreast of novel therapeutic modalities in a rapidly evolving field. The growing availability of synthetic coagulation factors has (at least in the western hemisphere) helped to reduce morbidity and therapeutic complications, while expanding the indications and usage of these agents. Promising advances in gene therapy may indeed introduce a sea change in the next decade or two. Curr Opin Anaesthesiol 15:19-25. © 2002 Lippincott Williams & Wilkins.Keywords
This publication has 64 references indexed in Scilit:
- Therapeutic choices for patients with hemophilia and high‐titer inhibitorsAmerican Journal of Hematology, 2001
- Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitorsBritish Journal of Haematology, 2000
- Familial antithrombin-III deficiency during cardiopulmonary bypass: a case reportPerfusion, 2000
- A novel (288delC) mutation in exon 2 of GPIIb associated with type I Glanzmann's thrombastheniaBritish Journal of Haematology, 2000
- Clinical trial results with antithrombin III in sepsisCritical Care Medicine, 2000
- Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?European Journal of Cardio-Thoracic Surgery, 2000
- Use of Heparin during Cardiopulmonary Bypass in Patients with a History of Heparin-Induced ThrombocytopeniaNew England Journal of Medicine, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Idiopathic Thrombocytopenic PurpuraPediatrics in Review, 2000
- Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery22The views expressed herein do not necessarily represent those of the Department of Veterans Affairs or the United States government.The Annals of Thoracic Surgery, 1999